10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology and to advance human health. Cited in more than 7,000 research papers, ...

10x Genomics’s shares are extremely volatile ... But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas ...

10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge ...

10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenue reaching $154M, growing 17% YoY. The company ...

Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results tomorrow after the bell. Here’s what investors should know. 10x Genomics beat analysts’ revenue expectations by 3. ...

PLEASANTON — 10x Genomics has marked a new phase in its remarkable expansion by opening a modern office building that has just sprouted in Pleasanton, coupled with plans for even more growth at ...

10x Genomics announced its first-quarter results ... in the first quarter based on generally accepted accounting principles (GAAP). In the prior-year period, 10x posted a GAAP net loss of $21.1 ...

July 14, 2022 /PRNewswire/ -- Following a comprehensive search process, 10x Genomics, Inc. (Nasdaq ... ability to operate strategically from first principles and his technical depth as a top ...

10x Genomics, Inc. TXG reported a loss for the third quarter on Tuesday. The company posted a quarterly loss of 30 cents per share, compared to market expectations for a loss of 34 cents per share.